This inventor holds 1 USPTO granted patent. Top assignees: Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 12,268 
1 out of 387 
Years Active: 2025
Title: Marie Glatz: Innovator in MASP Inhibitory Compounds
Introduction
Marie Glatz is a notable inventor recognized for her contributions to the field of biochemistry. She has made significant strides in the development of MASP inhibitory compounds, which have important applications in various medical and scientific fields. With a total of 1 patent, her work exemplifies the innovative spirit that drives advancements in healthcare.
Latest Patents
Marie Glatz holds a patent for "MASP Inhibitory Compounds and Uses Thereof." This patent highlights her research and development efforts in creating compounds that inhibit the MASP enzyme, which plays a crucial role in the immune response. Her invention has the potential to lead to new therapeutic strategies for treating various diseases.
Career Highlights
Throughout her career, Marie has worked with prominent companies such as Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Marie has had the opportunity to work alongside esteemed colleagues, including Donald Bierer and Ingo Flamme. These collaborations have enriched her research and expanded the impact of her inventions.
Conclusion
Marie Glatz is a pioneering inventor whose work in MASP inhibitory compounds showcases her dedication to advancing medical science. Her contributions are a testament to the importance of innovation in improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile